What is the current share price of Mankind Pharma Limited (MANKIND)?

As of the latest market update, Mankind Pharma Limited (MANKIND) is trading at ₹2,525.1. The stock has moved 0.27% down in the recent session.

What is the technical sentiment for MANKIND stock?

Based on our proprietary technical analysis, the current signal for MANKIND is "BUY". This analysis considers over 20+ indicators including RSI, MACD, and moving average crossovers to gauge market momentum.

What is the 52-week high and low for Mankind Pharma Limited?

Mankind Pharma Limited has seen a 52-week high of ₹2,716.5 and a 52-week low of ₹1,909.7. Comparing the current price to these levels helps investors understand the stock's relative valuation and volatility over the past year.

Which sector does Mankind Pharma Limited belong to?

Mankind Pharma Limited operates in the Healthcare sector, specifically within the Pharmaceuticals & Biotechnology industry. Its performance is often influenced by broader trends in the Healthcare segment.

What is the market capitalization of MANKIND?

Mankind Pharma Limited (MANKIND) has a market capitalization of approximately ₹1.04L Cr. This classifies it as a mid cap stock in the Indian market.

MANKIND

NSEF&O

Mankind Pharma Limited (MID CAP)

Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals

₹2,525.10

6.90 (0.27%)

High VOLATILITY

As on 10 Jul 2026

Advanced Chart

Price History

Market Cap

The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.

₹1.04L Cr

MID CAP

P/E Ratio

Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.

54.3

Industry

The specific business sector the company operates in. Useful for comparing with similar companies.

Pharmaceuticals

52-Week Range

The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.

52W Low₹1,909.7+32.2%

52W High₹2,716.5-7.0%

Current Price

₹2,525.10

Circuit Limits (20%)

The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.

Lower Circuit₹2,020.08

Upper Circuit₹3,030.12

Reference Price

₹2,525.10

Investment Checklist

Rounding Bottom on 1W (BREAKOUT CONFIRMED) — target ₹2691.35

Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹2551.8

Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

Composite score 50.16 (BUY) with 82.5% confidence

Volume divergence: Bearish (price up, volume down)

Technical Analysis

Analysis from 2026-07-10

Confidence

83%

Trend

BULLISH

Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

EMA20

2481.69

EMA50

2408.62

EMA200

2345.69

Price Action

UPTREND

BULLISH

Higher Highs6

Higher Lows8

Lower Highs3

Lower Lows1

Support & Resistance Levels

Resistance (Above)

₹2642.42

₹2716.50

Support (Below)

₹2509.93

₹2455.10

₹2412.37

₹2293.60

₹2204.83

Volume Analysis

TrendDECREASING

Change-35.80%

Unusual VolumeNo

Divergence Detected

Bearish (price up, volume down)

Stop Loss Levels

Fixed Risk

1% Risk₹2499.85

3% Risk₹2449.35

5% Risk₹2398.84

7% Risk (Custom)

₹2348.34

Technical Levels

1x ATR (Volatility)₹2457.71

2x ATR (Swing)₹2390.32

3x ATR (Trend)₹2322.93

Immediate Support₹2509.93

Moving Averages

EMA 9 (Short-term)₹2511.81

EMA 20 (Medium-term)₹2481.69

EMA 50 (Trend)₹2408.62

EMA 200 (Long-term)₹2345.69

Financials

Financial Analysis

Metric	Dec '24	Mar '25	Jun '25	Dec '25
Revenue	₹3,198.8 Cr	₹3,007.5 Cr	₹3,570.4 Cr	₹3,567.2 Cr
Net Profit	₹380.2 Cr	₹420.8 Cr	₹438.3 Cr	₹408.8 Cr
EPS	₹9.45	—	₹10.62	₹9.90
Operating Profit	₹896.4 Cr	₹899.6 Cr	₹929.8 Cr	₹888.8 Cr

Peer Comparison

Pharmaceuticals

Peer Comparison

Symbol	Name	Price	Change	P/E Ratio	Market Cap
SUNPHARMA	Sun Pharmaceutical Industries Limited	₹1,935.50	-0.17%	40.2	₹4.64L Cr large Cap
DIVISLAB	Divi's Laboratories Limited	₹6,836.00	+0.34%	70.4	₹1.81L Cr large Cap
TORNTPHARM	Torrent Pharmaceuticals Limited	₹4,901.50	+0.07%	77.5	₹1.66L Cr large Cap
CIPLA	Cipla Limited	₹1,439.40	-0.13%	30.1	₹1.16L Cr large Cap
ZYDUSLIFE	Zydus Lifesciences Limited	₹1,150.80	-0.71%	23.0	₹1.16L Cr large Cap
LUPIN	Lupin Limited	₹2,496.30	-0.28%	21.4	₹1.14L Cr mid Cap
MANKIND	Mankind Pharma Limited	₹2,525.10	-0.27%	54.3	₹1.04L Cr mid Cap
DRREDDY	Dr. Reddy's Laboratories Limited	₹1,244.30	-1.99%	25.6	₹1.04L Cr large Cap
AUROPHARMA	Aurobindo Pharma Limited	₹1,564.70	-1.43%	26.1	₹90.88K Cr mid Cap
LAURUSLABS	Laurus Labs Limited	₹1,537.80	+2.02%	91.5	₹83.02K Cr mid Cap
BIOCON	Biocon Limited	₹418.50	+3.70%	177.4	₹67.83K Cr mid Cap

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All

Ex Date	Purpose	Type
08 Aug 2025	Interim Dividend - Re 1 Per Share	INTERIM_DIVIDEND

Announcements

Latest updates

View All

Date	Description	Link
10 Jul 2026	Certificate under SEBI (Depositories and Participants) Regulations, 2018
10 Jul 2026	Copy of Newspaper Publication
09 Jul 2026	Shareholders meeting
01 Jul 2026	Copy of Newspaper Publication
30 Jun 2026	General Updates

Board Meetings

Upcoming and past meetings

View All

Date	Purpose	Links
19 May 2026	Financial Results
19 May 2026	Board Meeting Intimation
03 Feb 2026	Board Meeting Intimation	XBRL
03 Feb 2026	Financial Results
06 Nov 2025	Board Meeting Intimation	XBRL

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for MANKIND

View All

Explained - Why Jefferies is bearish on Dr. Reddy's and Cipla but bullish on Mankind Pharma

positive

CNBC TV18 - Markets 2d ago

Explained - Why Jefferies is bearish on Dr. Reddy's and Cipla but bullish on Mankind Pharma

Jefferies has mixed views on pharma stocks. It has an "underperform" rating on Dr Reddy's and Cipla, and a "buy" recommendation on Mankind Pharma.

CIPLAMANKINDHealthcare

Read full story

Stock Picks Today: HDFC AMC, Trent, Titan, Mankind Pharma And More On Brokerages' Radar

positive

NDTV Profit 4d ago

Stock Picks Today: HDFC AMC, Trent, Titan, Mankind Pharma And More On Brokerages' Radar

Check out top stocks under brokerages' radar heading into trade today.

MANKINDTITANTRENTConsumer DurablesConsumer Services

Read full story

Mankind Pharma partners Denovo Sciences for AI-led drug discovery

positive

ET Markets - Industry 9d ago

Mankind Pharma partners Denovo Sciences for AI-led drug discovery

Mankind Pharma has partnered with Denovo Sciences to accelerate drug discovery using artificial intelligence. This collaboration aims to significantly cut down early research timelines, enhance the quality of potential drug candidates, and ensure only the most promising ones advance. By combining Mankind Pharma's R&D prowess with Denovo's AI platform, the companies expect to bring effective and accessible treatments to patients faster, marking a significant step in innovation-driven research.

ADVANCEMANKINDSOLARASPARCChemicalsHealthcare

Read full story

MANKIND

Price History

Investment Checklist

Technical Analysis

Technical Analysis

Trend

Price Action

Support & Resistance Levels

Volume Analysis

Stop Loss Levels

Fixed Risk

Technical Levels

Moving Averages

Financials

Financial Analysis

Peer Comparison

Peer Comparison

Corporate Information

Large Deals

Corporate Actions

Announcements

Board Meetings

Corporate Events

Shareholding Pattern

Shareholding Pattern

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for MANKIND

Explained - Why Jefferies is bearish on Dr. Reddy's and Cipla but bullish on Mankind Pharma

Stock Picks Today: HDFC AMC, Trent, Titan, Mankind Pharma And More On Brokerages' Radar

Mankind Pharma partners Denovo Sciences for AI-led drug discovery

Frequently Asked Questions

What is the current share price of Mankind Pharma Limited (MANKIND)?

What is the technical sentiment for MANKIND stock?

What is the 52-week high and low for Mankind Pharma Limited?

Which sector does Mankind Pharma Limited belong to?

What is the market capitalization of MANKIND?